Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideyuki Akaza

Showing results (11-20 of 334) with videos related to

Pageof 34
Sort By:
Pharmacology|February 5, 2010
Future prospects for luteinizing hormone-releasing hormone analogues in prostate cancer treatmentHideyuki Akaza
Cancer Science|November 25, 2010
Combined androgen blockade for prostate cancer: review of efficacy, safety and cost-effectivenessHideyuki Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 12, 2013
[Epoch making development of new drugs for prostate cancer]Hideyuki Akaza
Cancer Science|March 1, 2012
Prostate cancer chemoprevention by soy isoflavones: role of intestinal bacteria as the "second human genome"Hideyuki Akaza
Nature Reviews. Urology|December 7, 2016
Bladder cancer: Advancing NMIBC treatment beyond current BCG formulationsHideyuki Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 30, 2015
[Genitourinary tumor]Hideyuki Akaza
Japanese Journal of Clinical Oncology|September 28, 2010
Aim of the working group on the Asian perspectives on cancer control: Asian perspective on prostate cancer preventionHideyuki Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 30, 2011
[Genitourinary cancer]Hideyuki Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 11, 2006
[The possibility of S-1 for the treatment of patients with urological cancers]Hideyuki Akaza
BJU International|January 19, 2007
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a Japanese perspective--the effect of primary androgen deprivation therapy on stage C prostate cancerHideyuki Akaza
Pageof 34

Showing results (11-20 of 334) with videos related to

Sort By:
Pageof 34
Pharmacology|February 5, 2010
Future prospects for luteinizing hormone-releasing hormone analogues in prostate cancer treatmentHideyuki Akaza
Cancer Science|November 25, 2010
Combined androgen blockade for prostate cancer: review of efficacy, safety and cost-effectivenessHideyuki Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 12, 2013
[Epoch making development of new drugs for prostate cancer]Hideyuki Akaza
Cancer Science|March 1, 2012
Prostate cancer chemoprevention by soy isoflavones: role of intestinal bacteria as the "second human genome"Hideyuki Akaza
Nature Reviews. Urology|December 7, 2016
Bladder cancer: Advancing NMIBC treatment beyond current BCG formulationsHideyuki Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 30, 2015
[Genitourinary tumor]Hideyuki Akaza
Japanese Journal of Clinical Oncology|September 28, 2010
Aim of the working group on the Asian perspectives on cancer control: Asian perspective on prostate cancer preventionHideyuki Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 30, 2011
[Genitourinary cancer]Hideyuki Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 11, 2006
[The possibility of S-1 for the treatment of patients with urological cancers]Hideyuki Akaza
BJU International|January 19, 2007
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a Japanese perspective--the effect of primary androgen deprivation therapy on stage C prostate cancerHideyuki Akaza
Pageof 34